These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 14677008

  • 1. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S.
    Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.
    Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
    [Abstract] [Full Text] [Related]

  • 3. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M.
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [Abstract] [Full Text] [Related]

  • 4. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.
    Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S.
    Intern Med; 2003 Sep; 42(9):800-5. PubMed ID: 14518665
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S.
    Clin Exp Rheumatol; 2007 Sep; 25(4):518-22. PubMed ID: 17888205
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.
    Okuda Y, Yamada T, Matsuura M, Takasugi K, Goto M.
    Amyloid; 2011 Sep; 18(3):108-11. PubMed ID: 21627560
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
    Maezawa A, Hiromura K, Mitsuhashi H, Tsukada Y, Kanai H, Yano S, Naruse T.
    Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
    [Abstract] [Full Text] [Related]

  • 11. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
    Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, Nakano M, Gejyo F.
    Mod Rheumatol; 2006 Jul; 16(5):294-9. PubMed ID: 17039310
    [Abstract] [Full Text] [Related]

  • 12. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.
    Clin Rheumatol; 2010 Dec; 29(12):1395-401. PubMed ID: 20440529
    [Abstract] [Full Text] [Related]

  • 13. Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.
    Yamada T, Okuda Y, Takasugi K, Itoh K, Igari J.
    Ann Rheum Dis; 2001 Feb; 60(2):124-7. PubMed ID: 11156544
    [Abstract] [Full Text] [Related]

  • 14. A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.
    Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N.
    Arthritis Rheum; 2001 Jun; 44(6):1266-72. PubMed ID: 11407685
    [Abstract] [Full Text] [Related]

  • 15. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Kumon Y, Hirata S, Takaoka H.
    Clin Exp Rheumatol; 2014 Jun; 32(4):501-8. PubMed ID: 24959698
    [Abstract] [Full Text] [Related]

  • 16. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
    Pamuk ÖN, Kalyoncu U, Aksu K, Omma A, Pehlivan Y, Çağatay Y, Küçükşahin O, Dönmez S, Çetin GY, Mercan R, Bayındır Ö, Çefle A, Yıldız F, Balkarlı A, Kılıç L, Çakır N, Kısacık B, Öksüz MF, Çobankara V, Onat AM, Sayarlıoğlu M, Öztürk MA, Pamuk GE, Akkoç N.
    Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
    [Abstract] [Full Text] [Related]

  • 17. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O.
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.